InsiderTrades

Form 4 for AVPT AvePoint, Inc.

Accepted 2026-03-18 00:00:00 ET · period of report 2026-03-16 · accession 0001437749-26-008915 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-03-18 2026-03-16 AVPT Jiang Tianyi CEO, Dir A - Grant $0.00 +147.3K 2.30M +7% $0
D 2026-03-18 2026-03-16 AVPT Jiang Tianyi CEO, Dir A - Grant $10.52 +252.6K 2.76M +10% +$2.66M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-16 A A 147,338 $0.00 2,299,627 D — — (F1) This security represents the Issuer's common stock as well as restricted stock units (each, an "RSU") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. (F2) Represents performance-based RSUs ("PRSUs") based upon two metrics: Annual recurring revenue compounded annual growth rate for the years 2026-2028 (70% weighted) and FY 2028 GAAP profitability (30% weighted). Actual payouts may represent 50% to 200% of granted value. These PRSUs will fully vest upon certification of the actual payouts by the Issuer's Compensation Committee after the performance period ends. (F3) Includes non-RSU common stock as well as aggregate vested and unvested RSUs held by the Reporting Person subject to the vesting schedules previously reported on Table I of Form 4s filed with the Securities and Exchange Commission on September 3, 2021, March 22, 2022, March 23, 2023, March 7, 2024, and March 18, 2025.
2 Derivative Stock Option (Right to Buy) 2026-03-16 A A 252,609 $10.52 2,756,670 D $10.52 · 2027-03-16 to 2036-03-16 252,609 Common Stock (F4) This security represents options to purchase the Issuer's common stock granted to the reporting person under the Issuer's 2021 Equity Incentive Plan. Each option represents the contingent right to receive, upon exercise of the option, one share of the Issuer's common stock. (F5) 25% of the shares underlying these options will vest on March 16, 2027, and the remaining options vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.